---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-077937"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2025-08-18T23:59:59+00:00"
generated_at: "2026-05-17T11:59:08.915065+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Unicycive discloses securities class action over phosphate binder NDA statements

## Summary
- Lawsuit filed in U.S. District Court for Northern District of California against company and certain officers.
- Alleges violations of federal securities laws regarding public statements on NDA for oxylanthanum carbonate phosphate binder.
- Product targets hyperphosphatemia in chronic kidney disease patients on dialysis.
- Company believes claims are meritless and intends to vigorously defend the lawsuit.
- Lawsuit became known to company on August 15, 2025.

## SEC filing metadata
- accession: 0001213900-25-077937
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2025-08-18T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390025077937/0001213900-25-077937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390025077937/ea0253753-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-077937
- JSON: https://secwatch.observer/filing/0001213900-25-077937.json
- Plain text: https://secwatch.observer/filing/0001213900-25-077937.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.